ERBB2 and breast carcinoma: In addition to classification into intrinsic subtypes such as luminal A, luminal B, HER2-enriched, basal-like, claudin-low and normal-like [2,3], breast cancer and triple-negative breast cancer (TNBC) in particular are known to be molecularly heterogeneous diseases.